Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q4 2025 | 21.70% |
| Q3 2025 | 14.17% |
| Q2 2025 | 21.37% |
| Q1 2025 | -20.86% |
| Q4 2024 | 9.35% |
| Q3 2024 | 1.04% |
| Q2 2024 | -7.17% |
| Q1 2024 | 0.09% |
| Q4 2023 | -15.27% |
| Q3 2023 | 9.25% |
| Q2 2023 | 17.64% |
| Q1 2023 | -12.46% |
| Q4 2022 | -2.37% |
| Q3 2022 | 0.00% |
| Q2 2022 | -100.00% |
| Q1 2022 | -67.46% |
| Q4 2021 | 6.13% |
| Q3 2021 | 103.09% |
| Q2 2021 | -22.84% |
| Q1 2021 | -27.77% |
| Q4 2020 | 127.44% |
| Q3 2020 | -46.14% |
| Q2 2020 | -89.87% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | -100.00% |
| Q1 2018 | -98.11% |
| Q4 2017 | 0.00% |
| Q3 2017 | 186.49% |
| Q2 2017 | -59.04% |
| Q1 2017 | 281.69% |
| Q4 2016 | -34.86% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |